Moderna said in a statement that it would be able to deliver about 500 million doses per year, and possibly up to a billion doses per year, starting in 2021. The company says it will not sell the vaccine at cost, but for profit. The government announced last week that it had made a $1.95 billion deal to buy 100 million doses of an mRNA vaccine made by Pfizer, in partnership with a German company, BioNTech. That vaccine is also expected to begin Phase 3 trials this month, and the government will buy it only if the trial proves it safe and effective. Curevac and Sanofi are also working on mRNA vaccines.

Source: New York Times July 27, 2020 09:34 UTC